Skip to main content
Environmental Health and Preventive Medicine logoLink to Environmental Health and Preventive Medicine
. 2004 Nov;9(6):262–265. doi: 10.1007/BF02898140

Association between APACHE II score and nosocomial infections in intensive care unit patients: A multicenter cohort study

Machi Suka 1,, Katsumi Yoshida 1, Jun Takezawa 2
PMCID: PMC2723611  PMID: 21432312

Abstract

Objective

To examine whether nosocomial infection risk increases with APACHE II score, which is an index of severity-of-illness, in intensive care unit (ICU) patients.

Methods

Using the Japanese Nosocomial Infection Surveillance database, 8,587 patients admitted to 34 participating ICUs between July 2000 and May 2002, aged 16 years or older, who had stayed in the ICU for 2 days or longer, had not transferred to another ICU, and had not been infected within 2 days after ICU admission, were followed until ICU discharge, Day 14 after ICU admission, or the development of nosocomial infection. Adjusted odds ratios with their 95% confidence intervals for nosocomial infections were calculated using logistic regression models, which incorporated sex, age, operation, ventilator; central venous catheter, and APACHE II score (0–5, 6–10, 11–15, 16–20, 21–25, 26–30, and 31+).

Results

There were 683 patients with nosocomial infections. Adjusted odds ratios for nosocomial infections gradually increased with APACHE II score. Women and elective operation showed significantly low odds ratios, while urgent operation, ventilator, and central venous catheter showed significantly high odds ratios. Age had no significant effect on the development of nosocomial infection.

Conclusions

Nosocomial infection risk increases with APACHE II score. APACHE II score may be a good predictor of nosocomial infections in ICU patients.

Key words: multicenter cohort study, ICU, APACHE II score, nosocomial infection

References

  • (1).Sakakibara Y, Takezawa J. Report of the Japan Nosocomial Infection Surveillance, ICU division. Infection Control 2002; 11: 530–536. (in Japanese)
  • (2).Furuya N, Yamaguchi K. Report of the Japan Nosocomial Infection Surveillance, Laboratory division. Infection Control. 2002;11:538–543. (in Japanese)
  • (3).Manabe K, Miyazaki H, Kawano F, Arakawa Y, Okabe N, Shindo N, Uno H. Report of the Japan Nosocomial Infection Surveillance, Hospitalwide division. Infection Control 2002; 11:546–550. (in Japanese)
  • (4).Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–829. [DOI] [PubMed]
  • (5).Bueno-Cavanillas A, Rodriguez-Contreras R, Lopez-Luque A, Delgado-Rodriguez M, Galves-Vargas R. Usefulness of severity indices in intensive care medicine as a predictor of nosocmoial infection risk. Intensive Care Med. 1991;17:336–339. [DOI] [PubMed]
  • (6).Chevret S, Hemmer M, Carlet J, Langer M. Incidence and risk factors of pneumonia acquired in intensive care units: results from a multicenter on 996 patients: European Cooperative Group on Nosocomial Pneumonia. Intensive Care Med. 1993;19:256–264. [DOI] [PubMed]
  • (7).FernandezCrehuet R, Diaz-Molina C, De Irala J, Martinez-Concha D, Salcedo-Leal I. Nosocomial infection in an intensive-care unit: incidence of risk factors. Infect Control Hosp Epidemiol. 1997;18:825–830. [PubMed]
  • (8).Hurr H, Hawley HB, Czachor JS, Marjert RJ, McCarthy MC. APACHE II and ISS scores as predictors of nosocomial infections in trauma patients. Am J Infect Control. 1999;27:79–83. [DOI] [PubMed]
  • (9).Sofianou DC, Constandinidis TC, Yannacou M, Anastasiou H, Sofianos E. Analysis of risk factors for ventilator-associated pneumonia in a multidisciplinary intensive care unit. Eur J Clin Microbiol Infect Dis. 2000;19:460–463. [DOI] [PubMed]
  • (10).Laupland KB, Zygun DA, Davies HD, Church DL, Louie TJ, Doig CJ. Incidence and risk factors for acquiring nosocomial urinary tract infection in the critically ill. J Crit Care. 2002; 17:50–57. [DOI] [PubMed]
  • (11).The 2003 Report of Health and Labour Sciences Research Grant (Research on Emergent or Revival Infections), “Research on network of drug-resistant infection surveillance”, 2003. (in Japanese)
  • (12).Takezawa J. Surveillance system for nosocomial infections due to drug-resistant organisms in Japan and other countries. Nippon Rinsho. 2001;59:126–134. (in Japanese) [PubMed]
  • (13).The 2000 Report of Health and Labour Sciences Research Grant (Research on Emergent or Revival Infections), “Research on development of drug-resistant infection surveillance system”, 2000. (in Japanese)
  • (14).Garner JS, Javis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections 1988. Am J Infect Control 1988;16:128–140. [DOI] [PubMed]
  • (15).Nosocomial infection rates for interhospital comparison: limitations and possible solutions. Infect Control Hosp Epidemiol. 1991;12:609–621. [PubMed]
  • (16).Cunnion KM, Weber DJ, Broadhead WE, Hanson LC, Piper CF, Rutala WA. Risk factors for nosocmial pneumonia: comparing adult critical-care populations. Am J Repir Crit Care Med. 1996;153:158–162. [DOI] [PubMed]
  • (17).McCusker ME, Perisse AR, Roghman MC. Severity-of-illness markers as predictors of nosocomial infection in adult intensive care unit patients. Am J Infect Control. 2002;30:139–144. [DOI] [PubMed]
  • (18).Keita-Perse O, Gaynes RP. Severity of illness scoring systems to adjust nosocomial infection rates: a review and commentary. Am J Infect Control. 1996;24:429–434. [DOI] [PubMed]

Articles from Environmental Health and Preventive Medicine are provided here courtesy of The Japanese Society for Hygiene

RESOURCES